Skip to main content

Grafa News and Videos — Page 1210

Latest

Grafa

Assembly Biosciences to advance oral HDV drug into rare cholestatic liver diseases

Assembly Biosciences (NASDAQ:ASMB) announced plans to expand the clinical development framework for its experimental compound ABI-6250, pushing the asset beyond its initial virology target into chronic cholestatic liver conditions.

Read more: Assembly Biosciences to advance oral HDV drug into rare cholestatic liver diseases
Grafa

Enhertu secures positive EU panel backing for first pan-tumor HER2 therapy

Enhertu (trastuzumab deruxtecan) moved a step closer to a milestone regulatory approval in Europe, securing a positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) as a tumor-agnostic treatment for advanced solid malignancies.

Read more: Enhertu secures positive EU panel backing for first pan-tumor HER2 therapy

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift